30-Day Survival After Temporary Right Ventricular Assist Devices: A Systematic Review

Document Type : Abstracts

Abstract

Acute right-sided heart failure (RHF) is a 
complex clinical syndrome, with a wide
range of clinical presentations, associated
with increased mortality and morbidity, but
with a scarcity of evidence-based
literature. Temporary right ventricular
assist device (t-RVAD) is a potential
treatment option for selected patients with
severe right ventricular dysfunction as a
bridge-to-recovery or as a permanent
solution.